A 69-year-old woman presented to the emergency room with chest pain and diaphoresis. She had been mostly A 69-year old bed-bound woman presented with chest pain and diaphoresis. Diagnostic imaging led to the diagnosis of bilateral extensive pulmonary emboli extending into all segmental branches. Tissue plasminogen activator (tPA) was administered via 2 separate EKOS catheters. Repeat evaluation after 33 hours revealed improvement of right ventricular size and function. EKOS catheters are useful for administration of fibrinolytics in pulmonary embolism.
INTRODUCTION
This is a case of a 69-year-old woman who presents to the ER with chest pain and diaphoresis. She had been mostly bedbound for the past 2 months due to a stroke 2 months ago with resulting residual hemiplegia. After diagnostic imaging was performed, she was diagnosed with extensive bilateral emboli involving the right and left main pulmonary arteries and extending into all segmental branches. The study decided to use catheter directed tPA via EKOS catheter. tPa was administered via 2 separate catheters over 12 hours for a total of 24mg. Then, the EKOS catheters were removed, and repeat echo done 33 hours after the initial echo showed improvement of right ventricular size and function. This case report aims to show benefits of using EKOS catheters for the administration of fibrinolytics in pulmonary embolism. valuable to demonstrate the cardiac dysfunction caused by an acute PE. [1] In this case, it was particularly important to determine the effects of the clot burden given the patients increased risks associated with tPA administration because of a history of recent stroke. In this case, EKOS catheters were used to administer tPA. The EKOS catheters have ultrasound transducers within the wire of the catheter, which uses ultrasound waves to accelerate the fibrinolytic process, and therefore decrease treatment time and decrease the total dose of thrombolytic agent needed which should translate into decreased morbidity and mortality. [2] A prospective multicenter study on 150 patients with acute massive or submassive pulmonary emboli who underwent ultrasound-facilitated, catheter-directed, low-dose fibrinolysis showed decreased right ventricular dilatation, decreased pulmonary hypertension, reduced clot burden, and decreased intracranial hemorrhages in these patients. Efficacy outcomes were measured within 48 h of initiation of fibrinolytic therapy. [3] In the case presented, there was also improved cardiac function after administration of tPA via EKOS catheters within 48 h. Therefore, this case supports the benefits of using EKOS catheters for the administration of fibrinolytics in PE.
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